The outcome of adding peripheral neuromodulation (stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder

Gynecological Endocrinology

Volumn 26, Issue 10, 2010, Pages 729-732

  Sancaktar, Murat ^a   Ceyhan, Seyit Temel ^b   Akyol, Ilker ^a   Muhcu, Murat ^a   Alanbay, Ibrahim ^b   Ercan, Cihangir Mutlu ^b   Atay, Vedat ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

anti muscarinic treatment; overactive bladder; Peripheral neuromodulation; quality of life

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; TOLTERODINE;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ELECTROSTIMULATION; FEMALE; HUMAN; NERVE STIMULATION; NEUROMODULATION; OVERACTIVE BLADDER; PERIPHERAL NEUROMODULATION; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SACRAL SPINAL CORD; SENSORY NERVE; SIDE EFFECT; SKIN IRRITATION; STOLLER AFFERENT NEUROSTIMULATION; SYMPTOM; TREATMENT OUTCOME; URINE INCONTINENCE;

EID: 77956524610     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003649815     Document Type: Article

References (17)

1. Sandvik H, Seim A, Vanvik A, Hunskaar S. Aseverity index for epidemiological surveys of female urinary incontinence: comparison with 48 hour pet-weighing tests. Neurourol Urodyn 2000;19:137-145.
2. Hanley J, Capewell A, Hagen S. Validity study of the severity index, a simple measure of urinary incontinence in women. BJM 2001;5:322:1096-1097.
3. Burgio KL, Locher JL, Goode PS. Behavioral and drug treatment for urge urinary incontinence in older women. JAMA 1998;280:1995-2000.
4. Wein AJ. Diagnosis and treatment of the overactive bladder. Urol 2003;62(suppl 5B):20-27.
5. Cam C, Sakalli M, Ay P, Cam M, Karateke A. Validation of the short forms of incontinence impact questionnaire (IIQ-7) and urogenital distress inventory (UDI-6) in a Turkish Population. Neurourol Urodyn 2007;26:129-133.
6. Radley SC, Rosario DJ, Chapple CR, Farkas AG. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol 2001;166: 2253-2258.
7. Matharu G, Donaldson MM, McGrother CW, Matthews RJ. Relationship between urinary symptoms reported in a postal questionnaire and urodynamic diagnosis. Neurourol Urodyn 2005;24:100-105.
8. Fitzgerald MP, Brubaker L. Urinary incontinence symptoms scores and urodynamic diagnosis. Neurourol Urodyn 2002;21:30-35.
9. Cardozo LD, Cooper D, Versi E. Oxybutinine chloride in the management of idiopatic detrusor instability. Neurourol Urodyn 1987;6:256-261.
10. Burgio KL, Matthews KA, Engel BT. Prevalance, incidence, and correlates of urinary incontinence in healthy, middle-aged women. J Urol 1991;146:1255-1259.
11. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997;104:988-993.
12. Nygaard IE, Kreder KJ. Pharmacologic therapy of lower urinary tract dysfunction. Clin Obstet Gynecol 2004;47:83-92.
13. Fall M, Lindstrom S. Electrical stimulation. A physicologic approach to the treatment of urinary incontinence. Urol Clin North Am 1991;393:10-18.
14. Fossberg E, Sorensen S, Ruutu M, Bakke A, et al. Maximal electrical stimulation in the treatment of unstable detrusor and urge incontinence. Eur Urol 1990;18:120-123.
15. Hasan ST, Robson WA, Pridie AK, Neal DE. Transcutaneous electrical nevre stimulation and temporary S3 neuromodula-tion in idiopatic detrusor instability. J Urol 1996;155:2005-2011.
16. Vandoninck V, van Balken MR, Agro EF, Petta F, et al. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn 2003;22:17-23.
17. Klingler HC, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for the treatment of detrusor overactivity. A urodynamic-based study. Urology 2000;56:766-771.